title: Drug use patterns of persons with Alzheimer's disease and related disorders living in the community.
abstract: OBJECTIVE
  To describe drug use patterns by persons with Alzheimer's disease, multi-infarct dementia, and mixed Alzheimer's disease and multi-infarct dementia.
  
  
  METHODS
  Multicenter, patient registry.
  
  
  METHODS
  Community-living persons evaluated in primary care, geriatric, and Alzheimer ambulatory settings.
  
  
  METHODS
  Of the 930 persons in three diagnostic categories, there were 671 with probable or possible Alzheimer's disease by NINCDS/ADRDA criteria or Alzheimer's disease by DSM-III-R criteria, 162 multi-infarct cases by DSM-III-R criteria, and 97 mixed cases by DSM-III-R criteria. In each diagnostic category, 65% were women, and the majority were 70 years or older.
  
  
  METHODS
  The average number of all prescription and non-prescription drugs and selected therapeutic categories by age, sex, diagnosis, and mini-mental status score at the time of diagnosis or evaluation.
  
  
  RESULTS
  Alzheimer patients average 2.3 drugs compared with multi-infarct (4.3; P < 0.0001) and mixed (3.7; P = 0.002) patients, and their pattern of drug use was different when stratified by therapeutic categories and drug classes. Drug use increased with age, and women used significantly more drugs than men in all three diagnostic categories. Women with Alzheimer's disease used significantly more cardiovascular drugs than men with Alzheimer's disease (P < 0.05). The lower the mini-mental status score in patients with any dementia, the greater the mean number of central nervous system agents used. The higher the mini-mental status score in a patient with multi-infarct or mixed dementia, the greater the use of cardiovascular drugs.
  
  
  CONCLUSIONS
  Drug use by Alzheimer patients was lower than in multi-infarct and mixed patients, primarily due to a lower prevalence of cardiovascular drugs.
authors: Department of Pharmacy Practice, College of Pharmacy, University of Illinois, Chicago 60612.
authors: T P
authors: TP
authors: Semla
authors: D
authors: D
authors: Cohen
authors: G
authors: G
authors: Paveza
authors: C
authors: C
authors: Eisdorfer
authors: P
authors: P
authors: Gorelick
authors: D
authors: D
authors: Luchins
authors: R
authors: R
authors: Hirschman
authors: S
authors: S
authors: Freels
authors: P
authors: P
authors: Levy
authors: J W
authors: JW
authors: Ashford
mesh_terms: D000367:Age Factors; D000368:Aged; D000544:Alzheimer Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000627:therapeutic use; D002641:Chicago / Q000453:epidemiology; D002908:Chronic Disease / Q000453:epidemiology; D015161:Dementia, Multi-Infarct / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D004358:Drug Therapy / Q000145:classification / Q000706:statistics & numerical data*; D004363:Drug Utilization; D005260:Female; D005431:Florida / Q000453:epidemiology; D006801:Humans; D007087:Illinois / Q000453:epidemiology; D008297:Male; D008609:Mental Status Schedule; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D015995:Prevalence; D012042:Registries; D012737:Sex Factors; D014922:Wisconsin / Q000453:epidemiology
chemical_list: D002317:Cardiovascular Agents; D002491:Central Nervous System Agents; D004366:Nonprescription Drugs